neuromuscular

ALS neurons brain synapses

Amylyx to pull failed ALS drug from market, cut 70% of staff

Amylyx is pulling the ALS drug Relyvrio from the U.S. and Canadian markets after a confirmatory trial failure.

Angus Liu Apr 4, 2024 10:06am

Argenx

Argenx's Vyvgart triumphs in rare neuromuscular disease study

Jul 17, 2023 10:55am

Duchenne muscular dystrophy

MDA and fitness clubs to raise money with national workout

Mar 30, 2023 9:15am

Title wellness health healthy food diet exercise fitness CREDIT Gettyudra

Muscular Dystrophy Association kicks off #30DaysofStrength

Sep 7, 2022 8:13am